fingolimod hydrochloride has been researched along with minocycline in 2 studies
Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (minocycline) | Trials (minocycline) | Recent Studies (post-2010) (minocycline) |
---|---|---|---|---|---|
2,771 | 157 | 2,062 | 6,579 | 502 | 2,921 |
Protein | Taxonomy | fingolimod hydrochloride (IC50) | minocycline (IC50) |
---|---|---|---|
Multidrug transporter MdfA | Escherichia coli K-12 | 2.6 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burton, JM; O'Connor, P | 1 |
Hahn, JN; Kaushik, DK; Mishra, MK; Silva, C; Wang, J; Yong, VW | 1 |
1 review(s) available for fingolimod hydrochloride and minocycline
Article | Year |
---|---|
Novel oral agents for multiple sclerosis.
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Cladribine; Clinical Trials as Topic; Dimethyl Fumarate; Fingolimod Hydrochloride; Fumarates; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Interferon beta-1b; Interferon-beta; Isoxazoles; Leflunomide; Minocycline; Multiple Sclerosis; Mycophenolic Acid; Propylene Glycols; Pyridones; Quinolones; Sphingosine | 2007 |
1 other study(ies) available for fingolimod hydrochloride and minocycline
Article | Year |
---|---|
Impact of Minocycline on Extracellular Matrix Metalloproteinase Inducer, a Factor Implicated in Multiple Sclerosis Immunopathogenesis.
Topics: Animals; Anti-Bacterial Agents; Basigin; Central Nervous System; Clinical Trials, Phase III as Topic; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Fingolimod Hydrochloride; Fumarates; Humans; Interferon-beta; Lymphocyte Activation; Maleates; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Minocycline; Monocytes; Multiple Sclerosis; T-Lymphocytes; Tissue Inhibitor of Metalloproteinase-1 | 2016 |